These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 16838023)

  • 1. Evidence for an oncogenic role of AHI-1 in Sezary syndrome, a leukemic variant of human cutaneous T-cell lymphomas.
    Ringrose A; Zhou Y; Pang E; Zhou L; Lin AE; Sheng G; Li XJ; Weng A; Su MW; Pittelkow MR; Jiang X
    Leukemia; 2006 Sep; 20(9):1593-601. PubMed ID: 16838023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells.
    Kennah E; Ringrose A; Zhou LL; Esmailzadeh S; Qian H; Su MW; Zhou Y; Jiang X
    Blood; 2009 May; 113(19):4646-55. PubMed ID: 19211505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cutaneous lymphoma of the Sézary and Bouvrain type. Progress in physiopathologic and therapeutic outlook].
    Bagot M
    Bull Acad Natl Med; 1998; 182(5):927-37; discussion 937-8. PubMed ID: 9735499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mouse model for Sézary syndrome using xenotransplantation of Sézary cells into immunodeficient RAG2(-/-) γc(-/-) mice.
    van der Fits L; Rebel HG; Out-Luiting JJ; Pouw SM; Smit F; Vermeer KG; van Zijl L; Tensen CP; Weijer K; Vermeer MH
    Exp Dermatol; 2012 Sep; 21(9):706-9. PubMed ID: 22897578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulated expression in Ph+ human leukemias of AHI-1, a gene activated by insertional mutagenesis in mouse models of leukemia.
    Jiang X; Zhao Y; Chan WY; Vercauteren S; Pang E; Kennedy S; Nicolini F; Eaves A; Eaves C
    Blood; 2004 May; 103(10):3897-904. PubMed ID: 14751929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracutaneous transformation into a high-grade lymphoma: a potential pitfall in the management of patients with Sézary syndrome.
    Michaelis S; Kazakov DV; Burg G; Dummer R; Kempf W
    Int J Dermatol; 2006 Mar; 45(3):277-9. PubMed ID: 16533228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated expression of COOH-terminally truncated Stat5 and loss of IL2-inducible Stat5-dependent gene expression in Sezary Syndrome.
    Mitchell TJ; Whittaker SJ; John S
    Cancer Res; 2003 Dec; 63(24):9048-54. PubMed ID: 14695224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.
    Waldmann TA; Greene WC; Sarin PS; Saxinger C; Blayney DW; Blattner WA; Goldman CK; Bongiovanni K; Sharrow S; Depper JM
    J Clin Invest; 1984 Jun; 73(6):1711-8. PubMed ID: 6327770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
    Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
    Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroviral transduction of protein kinase C-gamma into tumor-specific T cells allows antigen-independent long-term growth in IL-2 with retention of functional specificity in vitro and ability to mediate tumor therapy in vivo.
    Chen W; Schweins E; Chen X; Finn OJ; Cheever MA
    J Immunol; 1994 Oct; 153(8):3630-8. PubMed ID: 7930583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal cytokine expression in Sézary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies.
    Tendler CL; Burton JD; Jaffe J; Danielpour D; Charley M; McCoy JP; Pittelkow MR; Waldmann TA
    Cancer Res; 1994 Aug; 54(16):4430-5. PubMed ID: 7913876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-7 is a growth factor for Sézary lymphoma cells.
    Dalloul A; Laroche L; Bagot M; Mossalayi MD; Fourcade C; Thacker DJ; Hogge DE; Merle-Béral H; Debré P; Schmitt C
    J Clin Invest; 1992 Sep; 90(3):1054-60. PubMed ID: 1381718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on apoptosis and cell cycle arrest contribute to the antitumor responses of interleukin-27 mediated by retrovirus in human pancreatic carcinoma cells.
    Liu L; Meng J; Zhang C; Duan Y; Zhao L; Wang S; Shan B
    Oncol Rep; 2012 May; 27(5):1497-503. PubMed ID: 22293948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-12 reverses cytokine and immune abnormalities in Sezary syndrome.
    Rook AH; Kubin M; Cassin M; Vonderheid EC; Vowels BR; Wolfe JT; Wolf SF; Singh A; Trinchieri G; Lessin SR
    J Immunol; 1995 Feb; 154(3):1491-8. PubMed ID: 7822812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sézary T-cell-activating factor induces functional interleukin 2 receptors on T-cells derived from patients with Sézary syndrome.
    Abrams JT; Ghosh SK; DeFreitas E
    Cancer Res; 1993 Nov; 53(22):5501-6. PubMed ID: 8221690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmissibility of murine stem cell virus-based retroviral vectors carrying both interleukin-12 cDNAs and a third gene: implications for immune gene therapy.
    Lieu FH; Hawley TS; Fong AZ; Hawley RG
    Cancer Gene Ther; 1997; 4(3):167-75. PubMed ID: 9171935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant and nonmalignant T cell lines from human T cell lymphotropic virus type I-negative patients with Sézary syndrome.
    Abrams JT; Lessin SR; Ghosh SK; Nowell PC; Ju W; Vonderheid EC; Rook AH; DeFreitas E
    J Immunol; 1991 Mar; 146(5):1455-62. PubMed ID: 1847162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions.
    Schilz AJ; Schiedlmeier B; Kühlcke K; Fruehauf S; Lindemann C; Zeller WJ; Grez M; Fauser AA; Baum C; Eckert HG
    Mol Ther; 2000 Dec; 2(6):609-18. PubMed ID: 11124062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mu-Opioid receptor is induced by IL-13 within lymph nodes from patients with Sézary syndrome.
    Bénard A; Cavaillès P; Boué J; Chapey E; Bayry J; Blanpied C; Meyer N; Lamant L; Kaveri SV; Brousset P; Dietrich G
    J Invest Dermatol; 2010 May; 130(5):1337-44. PubMed ID: 20107485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.